Answers are grounded in this paper and cite their sources.
Objective Diabetes imposes a significant public health burden in South Africa, yet public sector glycated hemoglobin (HbA1c) testing patterns remain poorly characterized. This study examined HbA1c testing adherence and glycemic control in the Western Cape across the COVID-19 pandemic. Methods A retrospective observational study used National Health Laboratory Service data for adults in the Western Cape (January 2017-December 2022) across pre-pandemic, pandemic, and post-pandemic periods. A linear mixed-effects model, restricted to patients with a baseline HbA1c ≥7%, assessed associations between study period, facility location, testing interval, and HbA1c. Results After exclusions, 1,191,486 HbA1c measurements from 546,466 patients were included. Testing adherence was poor throughout, with 89.4% of pandemic-period tests and 88.7% of post-pandemic tests performed later than recommended. In patients with a baseline HbA1c ≥7% and at least two measurements, adjusted mean HbA1c increased from 9.6% pre-pandemic to 9.9% during the pandemic, then decreased to 9.7% post-pandemic (eight-month period), without returning to pre-pandemic levels. Non-metropolitan location was associated with higher HbA1c; testing interval length showed no meaningful association. Conclusions These findings suggest that the pandemic compounded pre-existing weaknesses in HbA1c monitoring rather than creating an entirely new problem. Continuous structural investments, including decentralized HbA1c testing and community-based monitoring, are needed to strengthen chronic disease care during future health-system disruptions.
No takes yet. Share an insight, caveat, or question.
Kruger et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: